| Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study NJ Harlaar, M Koller, SJ de Jongh, BL van Leeuwen, PH Hemmer, ... The Lancet Gastroenterology & Hepatology 1 (4), 283-290, 2016 | 204 | 2016 |
| Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging 18F-FDG PET Imaging Biomarkers in … RJ Beukinga, JB Hulshoff, VEM Mul, W Noordzij, G Kats-Ugurlu, ... Radiology 287 (3), 983-992, 2018 | 101 | 2018 |
| Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma G Kats‐Ugurlu, I Roodink, M de Weijert, D Tiemessen, C Maass, K Verrijp, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 93 | 2009 |
| Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer with textural features derived from pretreatment 18F-FDG PET/CT imaging RJ Beukinga, JB Hulshoff, LV van Dijk, CT Muijs, JGM Burgerhof, ... Journal of nuclear medicine 58 (5), 723-729, 2017 | 83 | 2017 |
| Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis B Küsters, G Kats, I Roodink, K Verrijp, P Wesseling, DJ Ruiter, ... Oncogene 26 (39), 5808-5815, 2007 | 65 | 2007 |
| Niacin (vitamin B3) supplementation in patients with serotonin-producing neuroendocrine tumor G Bouma, M van Faassen, G Kats-Ugurlu, EGE de Vries, IP Kema, ... Neuroendocrinology 103 (5), 489-494, 2016 | 56 | 2016 |
| Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression I Roodink, G Kats, L van Kempen, M Grunberg, C Maass, K Verrijp, ... The American journal of pathology 173 (6), 1873-1881, 2008 | 54 | 2008 |
| Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining MJ van der Wel, LC Duits, RE Pouw, CA Seldenrijk, GJA Offerhaus, ... Histopathology 72 (6), 1015-1023, 2018 | 38 | 2018 |
| Prognostic value of the circumferential resection margin in esophageal cancer patients after neoadjuvant chemoradiotherapy JB Hulshoff, Z Faiz, A Karrenbeld, G Kats-Ugurlu, JGM Burgerhof, JK Smit, ... Annals of surgical oncology 22, 1301-1309, 2015 | 36 | 2015 |
| Effectiveness of colorectal cancer (CRC) screening on all-cause and CRC-specific mortality reduction: a systematic review and meta-analysis S Zheng, JJA Schrijvers, MJW Greuter, G Kats-Ugurlu, W Lu, GH de Bock Cancers 15 (7), 1948, 2023 | 31 | 2023 |
| Treatment outcomes of advanced digestive well-differentiated grade 3 NETs L de Mestier, A Lamarca, J Hernando, W Zandee, T Alonso-Gordoa, ... Endocrine-Related Cancer 28 (8), 549-561, 2021 | 27 | 2021 |
| C-Met targeted fluorescence molecular endoscopy in Barrett's esophagus patients and identification of outcome parameters for phase-I studies SJ de Jongh, FJ Voskuil, I Schmidt, A Karrenbeld, G Kats-Ugurlu, ... Theranostics 10 (12), 5357, 2020 | 27 | 2020 |
| Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX‐specific chimeric monoclonal antibody cG250 JC Oosterwijk‐Wakka, G Kats‐Ugurlu, WPJ Leenders, LALM Kiemeney, ... BJU international 107 (1), 118-125, 2011 | 27 | 2011 |
| Analysis of metastases rates during follow-up after endoscopic resection of early “high-risk” esophageal adenocarcinoma EA Nieuwenhuis, SN van Munster, SL Meijer, LAA Brosens, M Jansen, ... Gastrointestinal endoscopy 96 (2), 237-247. e3, 2022 | 26 | 2022 |
| Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study AW Gotink, SEM van de Ven, FJC Ten Kate, D Nieboer, L Suzuki, ... Endoscopy 54 (02), 109-117, 2022 | 26 | 2022 |
| Neuroendocrine tumours and their microenvironment LD de Hosson, TJ Takkenkamp, G Kats-Ugurlu, G Bouma, M Bulthuis, ... Cancer Immunology, Immunotherapy 69 (8), 1449-1459, 2020 | 21 | 2020 |
| Safe and successful treatment of acute cellular rejection of an intestine and abdominal wall transplant with vedolizumab G Trentadue, G Kats-Ugurlu, T Blokzijl, GFH Diercks, JW Haveman, ... Transplantation direct 6 (2), e527, 2020 | 21 | 2020 |
| Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments G Kats-Ugurlu, E Oosterwijk, S Muselaers, J Oosterwijk-Wakka, ... Neoplasia 16 (3), 221-228, 2014 | 21 | 2014 |
| Prophylactic medication for the prevention of endoscopic recurrence in Crohn’s disease: a prospective study based on clinical risk stratification JHC Arkenbosch, EMJ Beelen, G Dijkstra, M Romberg-Camps, ... Journal of Crohn's and Colitis 17 (2), 221-230, 2023 | 20 | 2023 |
| Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study … BJS open 5 (3), zrab029, 2021 | 20 | 2021 |
